The theoreticalanalysisandexperimentalresultsdemonstrate that the improvedschemeincreasestheprobabilityoftracingat leastonecolluder who useslinearcombinationattack.
But AtheroGenics claims that the trial actually shows a statistically significant benefit in preventing the combination of heart attack, stroke and death.
These negative trends seem to have been driven by the caustic combination of a significant increase in attack sophistication and an appreciable reduction in the know-how required to effectively deploying and operating malware.